InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Beshar Luke M, 董事. Director active across 1 company, notably Protara Therapeutics, Inc.. Aggregated, 3 reports have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €109k. History available since 10 March 2022. The latest transaction was filed on 30 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Luke M. Beshar serves as a Board Member at Protara Therapeutics, Inc. In this role, he participates in the governance and strategy of the company, which specializes in therapeutic treatments. His experience in the industry is beneficial to the board.